Abstract

Soft tissue sarcoma (STS) is a rare and diverse group of malignancies originating from soft tissues, presenting significant challenges in diagnosis and treatment. However, recent advancements in STS research and treatment have brought new hope to patients and healthcare professionals alike. This abstract highlights some of the key breakthroughs in STS research and treatment strategies. Genomic profiling has emerged as a critical tool, providing insights into the genetic alterations and molecular pathways driving STS development. By identifying specific gene mutations unique to various subtypes, personalized treatment approaches, including targeted therapies and immunotherapies, have been developed to exploit tumor vulnerabilities effectively.

Keywords: Soft tissue sarcoma; Genomic profiling; Healthcare; Research and treatment